GCS
STIM icon

Gordian Capital (Singapore)’s Neuronetics STIM Stock Holding History

Gordian Capital (Singapore)’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,000
Closed -$90.5K – 167
2025
Q1 		$90.5K Buy
+24,000
New +$87.6K 0.06% 106

Other funds holding STIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Gordian Capital (Singapore)'s STIM Position: Q2 2025 in Review

Gordian Capital (Singapore) sold out of Neuronetics (STIM) in Q2 2025, closing a stake of 24,000 shares — an estimated $90.5K sold.

Gordian Capital (Singapore) first reported a position in STIM in Q1 2025 and held it in 1 quarter. The position peaked at $90.5K in Q1 2025. 90 funds tracked by Wall St. Rank hold STIM as of Q2 2025.

  • Gordian Capital (Singapore) reported no remaining Neuronetics position as of Q2 2025 after selling out during the quarter.
  • Gordian Capital (Singapore) sold 24,000 Neuronetics shares in Q2 2025, an estimated $90.5K.
  • Gordian Capital (Singapore) first reported a position in Neuronetics in Q1 2025 and held it in 1 quarter.
  • Gordian Capital (Singapore)'s Neuronetics position peaked at $90.5K in Q1 2025.
  • 90 funds tracked by Wall St. Rank held Neuronetics as of Q2 2025.

Based on Gordian Capital (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.